September 16, 2021

CV Safety of Prostate Cancer Therapies ‘Remains Unresolved’: PRONOUNCE

Salim Hayek MD, FACC gives fresh perspective on the null results of the PRONOUNCE trial on cardiotoxic prostate cancer therapies.